Solara Active Pharma Sciences Ltd Quarterly Results

Gross Sales

319.15

273.01

300.31

346.95

363.49

Excise Duty

0

0

0

0

0

Net Sales

319.15

273.01

300.31

346.95

363.49

Other Operating Income

0

0

0

0

0

Other Income

0.98

5.95

1.49

0.32

0.56

Total Income

320.13

278.96

301.8

347.27

364.05

Total Expenditure

262.13

227.64

242.63

285.64

321.57

PBIDT

58

51.32

59.17

61.63

42.48

Interest

23.9

29.12

26.54

28.28

30.87

PBDT

34.1

22.2

32.63

33.35

11.61

Depreciation

23.58

24.3

24.54

25.34

25.07

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

10.52

-2.1

8.09

8.01

-13.46

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

10.52

-2.1

8.09

8.01

-13.46

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

10.52

-2.1

8.09

8.01

-13.46

EPS (Unit Curr.)

2.46

-0.93

2.03

2.54

-3.5

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

44.34

40.25

40.25

40.21

42

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.17

18.79

19.7

17.76

11.68

PBDTM(%)

10.68

8.13

10.86

9.61

3.19

PATM(%)

3.29

-0.76

2.69

2.3

-3.7